MARKS JAMES D has a total of 11 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are EUREKA THERAPEUTICS INC, GILLIES STEPHEN D and JO DAEWOONG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Computer technology | |
#5 | IT methods for management | |
#6 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Unspecified technologies | |
#6 | Data processing systems | |
#7 | Analysing materials | |
#8 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Marks James D | 11 |
#2 | Lou Jianlong | 4 |
#3 | Geren Isin N | 3 |
#4 | Razai Ali | 3 |
#5 | Poul Marie Alix | 2 |
#6 | Amersdorfer Peter | 2 |
#7 | Rodriguez Maria Consuelos Garcia | 1 |
#8 | Garcia Maria Consuelo | 1 |
#9 | Dong Jianbo | 1 |
#10 | Geren Isin | 1 |
Publication | Filing date | Title |
---|---|---|
US2015030600A1 | Antibodies for botulinum neurotoxins | |
US2010166773A1 | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins | |
US7483838B1 | System and method for recruitment of candidates for clinical trials while maintaining security |